V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Catalent Executive Compensation (FY23)

CTLT · Executive and director compensation, fiscal 2022 to 2023

The paid brief on Catalent

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 7, 2026Latest filing (DEF 14A): December 15, 2023
2 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Catalent brief$1,500Get the executive brief
282 figures on this page, cited to the filing that reported them. See the citations
Chief executive, fiscal 2023
◇
Alessandro Maselli
Median of the other named officers
$3,264,770
6 officers, excluding the chief executive

More on Catalent

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2022 to fiscal 2023
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Alessandro Maselli: $3,234,030 → $6,583,672 (103.6% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Catalent's chief executive and what were they paid?
Total compensation for Alessandro Maselli, President and Chief Executive Officer, came to $6,583,672 in fiscal 2023. Maselli's total moved 103.6% higher from the $3,234,030 reported for fiscal 2022.
Which companies are in Catalent's peer group?
The disclosed peer group names Agilent Technologies, Inc., Align Technology, Inc., Bio-Rad Laboratories, Inc., Biogen Inc. and Boston Scientific Corporation, among others.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Chiminski
Former Executive Chair
◇—◇◇◇—◇◇
Alessandro Maselli
President and Chief Executive Officer
◇—◇◇◇—◇◇
Steven Fasman
Former Executive Vice President & Chief Administrative Officer
◇—◇◇◇—◇◇
Aristippos Gennadios
Group President, Pharma and Consumer Health
◇—◇◇◇—◇◇
Thomas Castellano
Former Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Alessandro Maselli
President and Chief Executive Officer
◇—◇◇——◇◇
John Chiminski
Former Executive Chair
Departed during or after this year
◇—◇———◇◇
Manja Boerman
Former President, Division Head for Biomodalities
Departed during or after this year
◇—◇◇——◇◇
Aristippos Gennadios
Group President, Pharma and Consumer Health
◇—◇◇◇—◇◇
Thomas Castellano
Former Senior Vice President and Chief Financial Officer
Departed during or after this year
◇—◇◇——◇◇
Steven Fasman
Former Executive Vice President & Chief Administrative Officer
Departed during or after this year
◇—◇◇◇—◇◇
Ricky Hopson
President, Division Head for Clinical Development & Supply and Former Interim Chief Financial Officer
Departed during or after this year
Served on an interim basis
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2023
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Alessandro MaselliRSU◇——◇——◇
Alessandro MaselliOPTION◇——◇—◇◇
Alessandro MaselliPSU◇◇◇—◇—◇
Alessandro MaselliPSU◇◇◇—◇—◇
Aristippos GennadiosPSU◇◇◇—◇—◇
Aristippos GennadiosPSU◇◇◇—◇—◇
Aristippos GennadiosOPTION◇——◇—◇◇
Aristippos GennadiosRSU◇——◇——◇
Aristippos GennadiosRSU◇——◇——◇
John ChiminskiRSU◇——◇——◇
Manja BoermanPSU◇◇◇—◇—◇
Manja BoermanPSU◇◇◇—◇—◇
Manja BoermanOPTION◇——◇—◇◇
Manja BoermanPSU◇◇◇—◇—◇
Manja BoermanRSU◇——◇——◇
Ricky HopsonPSU◇◇◇—◇—◇
Ricky HopsonRSU◇——◇——◇
Ricky HopsonOPTION◇——◇—◇◇
Ricky HopsonPSU◇◇◇—◇—◇
Steven L. FasmanRSU◇——◇——◇
Steven L. FasmanPSU◇◇◇—◇—◇
Steven L. FasmanPSU◇◇◇—◇—◇
Steven L. FasmanOPTION◇——◇—◇◇
Thomas CastellanoPSU◇◇◇—◇—◇
Thomas CastellanoRSU◇——◇——◇
Thomas CastellanoOPTION◇——◇—◇◇
Thomas CastellanoPSU◇◇◇—◇—◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2023 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Alessandro MaselliRSU◇◇——
Option◇—◇7/26/2031
Option◇—◇7/22/2029
PSU◇◇——
Option◇—◇7/26/2032
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇7/30/2030
Steven FasmanRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Manja BoermanRSU◇◇——
Aristippos GennadiosRSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Ricky HopsonRSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
John ChiminskiRSU◇◇——
Thomas CastellanoRSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2023
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
J. Martin Carroll
◇◇————◇
John J. Greisch
Board chair
◇◇————◇
Jack Stahl
Lead independent director
◇◇————◇
Gregory T. Lucier
◇◇————◇
Donald E. Morel Jr
◇◇————◇
Rosemary A. Crane
◇◇————◇
Rolf Classon
◇◇————◇
Christa Kreuzburg
◇◇————◇
Madhavan Balachandran
◇◇————◇
Michael J. Barber
◇◇————◇
Karen Flynn
◇◇————◇
Peter Zippelius
◇◇————◇
Alessandro Maselli, Frank A. D'Amelio, Stephanie Okey, John Chiminski, Michelle R. Ryan and Steven K. Barg served on the board in fiscal 2023 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.
Stock ownership guideline: 5x annual cash retainer

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2023
  • Agilent Technologies, Inc. A
  • Align Technology, Inc. ALGN
  • Bio-Rad Laboratories, Inc. BIO
  • Biogen Inc. BIIB
  • Boston Scientific Corporation BSX
  • Hologic, Inc. HOLX
  • Horizon Pharma plc HZNP
  • Incyte Corporation INCY
  • Jazz Pharmaceuticals plc JAZZ
  • Mettler-Toledo International Inc. MTD
  • Perrigo plc PRGO
  • STERIS plc STE
  • The Cooper Companies, Inc. COO
  • Vertex Pharmaceuticals Incorporated VRTX
  • West Pharmaceutical Services, Inc. WST
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Catalent files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Catalent disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Catalent sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Catalent's disclosed peer group is defensible, who names Catalent back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
282 figures on this page, cited to the filing that reported them.
282 cited to the filing

Documents cited

  1. 0001193125-23-295996
    DIRECTOR COMPENSATION · Director Compensation for Fiscal 2023 · Fiscal 2023 Grants of Plan-Based Awards Table · Fiscal 2023 Outstanding Equity Awards at Year-End Table · and 1 more section
  2. 0001193125-22-246052
    Fiscal 2022 Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Catalent executive compensation, FY2022–FY2023.” https://intel.velarion.ai/comp/CTLT (accessed 2026).
Short form: data: Velarion

The paid brief for Catalent

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
2 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Catalent and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Catalent discloses

The companies named in CTLT's own disclosed peer group.

Agilent Technologies, Inc.Align Technology, Inc.Bio-Rad Laboratories, Inc.Biogen Inc.Boston Scientific CorporationHologic, Inc.Horizon Pharma plcIncyte CorporationJazz Pharmaceuticals plcMettler-Toledo International Inc.Perrigo plcSTERIS plcThe Cooper Companies, Inc.Vertex Pharmaceuticals IncorporatedWest Pharmaceutical Services, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy